Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Should You Sell?

by · The Markets Daily

Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $8.35, but opened at $7.92. Anbio Biotechnology shares last traded at $8.3740, with a volume of 11,978 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Anbio Biotechnology currently has an average rating of “Sell”.

View Our Latest Stock Analysis on NNNN

Anbio Biotechnology Stock Performance

The firm’s 50 day moving average price is $11.91 and its 200-day moving average price is $20.97.

About Anbio Biotechnology

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.

See Also